FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095064118> ?p ?o ?g. }

• W2095064118 endingPage "966" @default.
• W2095064118 startingPage "959" @default.
• W2095064118 abstract "Arylboronates afford rapid aqueous (18)F-labeling via the creation of a highly polar (18)F-aryltrifluoroborate anion ((18)F-ArBF3(-)).Radiosynthesis of an (18)F-ArBF3(-) can be successfully applied to a clinically relevant peptide. To test this hypothesis, we labeled dimeric-cylcoRGD, [c(RGDfK)]2E because a) it is molecularly complex and provides a challenging substrate to test the application of this technique, and b) [c(RGDfK)]2E has already been labeled via several (18)F-labeling methods which provide for a preliminary comparison.To validate this labeling method in the context of a complex and clinically relevant tracer to show tumor-specific uptake ex vivo with representative PET images in vivo.An arylborimidine was conjugated to [c(RGDfK)]2E to give the precursor [c(RGDfK)]2E-ArB(dan), which was aliquoted and stored at -20 °C. Aliquots of 10 or 25 nmol, containing only micrograms of precursor, were labeled using relatively low levels of (18)F-activity. Following purification eight mice (pre-blocked/unblocked) with U87M xenograft tumors were injected with [c(RGDfK)]2E-(18)F-ArBF3(-) (n = 4) for ex vivo tissue dissection. Two sets of mice (pre-blocked/unblocked) were also imaged with PET-CT (n = 2).The [c(RGDfK)]2E-ArB(dan) is converted within 15 min to [c(RGDfK)]2E-(18)F-ArBF3(-) in isolated radiochemical yields of ~10% (n = 3) at a minimum effective specific activity of 0.3 Ci/μmol. Biodistribution shows rapid clearance to the bladder via the kidney resulting in high tumor-to-blood and tumor-to-muscle ratios of >9 and >6 respectively while pre-blocking with [c(RGDfK)]2E showed high tumor specificity. PET imaging showed good contrast between tumor and non-target tissues confirming the biodistribution data.An arylborimidine-RGD peptide is rapidly (18)F-labeled in one step, in good yield, at useful specific activity. Biodistribution studies with blocking controls show tumor specificity, which is corroborated by PET images. Advances in Knowledge and Implications for patient Care: Despite many antecedent examples of labeled RGD tracers, this work is the first to show direct aqueous labeling of bisRGD with an (18)F-ArBF3(-). Labeling occurs in near record rapidity (45 min) at useful effective specific activities and competitive yields for high contrast tumor specific images. As bisRGD has been imaged in humans with several prosthetics, this work suggests potential clinical applications of tracers appended with an (18)F-ArBF3(-). More generally, the ability to label a molecularly complex tracer suggests that this method could be useful to label many other peptides. Furthermore, these results portend the development of kits that use only microgram quantities of lyophilized precursor for on demand labeling. The ability to perform one-step aqueous labeling in under an hour to provide tracers with high T:NT ratios has important implications for developing radiotracers for use in fundamental research and in preclinical tracer studies." @default.
• W2095064118 created "2016-06-24" @default.
• W2095064118 creator A5004769994 @default.
• W2095064118 creator A5022775390 @default.
• W2095064118 creator A5034838802 @default.
• W2095064118 creator A5049887641 @default.
• W2095064118 creator A5063090346 @default.
• W2095064118 creator A5070008388 @default.
• W2095064118 creator A5072886386 @default.
• W2095064118 date "2013-11-01" @default.
• W2095064118 modified "2023-09-26" @default.
• W2095064118 title "Single step 18F-labeling of dimeric cycloRGD for functional PET imaging of tumors in mice" @default.
• W2095064118 cites W117461572 @default.
• W2095064118 cites W1508058484 @default.
• W2095064118 cites W1937872799 @default.
• W2095064118 cites W1968195961 @default.
• W2095064118 cites W1973269553 @default.
• W2095064118 cites W1975024262 @default.
• W2095064118 cites W1977087475 @default.
• W2095064118 cites W1977660972 @default.
• W2095064118 cites W1979354807 @default.
• W2095064118 cites W1979373927 @default.
• W2095064118 cites W1993772770 @default.
• W2095064118 cites W1996092263 @default.
• W2095064118 cites W2002774887 @default.
• W2095064118 cites W2006474870 @default.
• W2095064118 cites W2008335914 @default.
• W2095064118 cites W2016918536 @default.
• W2095064118 cites W2017017831 @default.
• W2095064118 cites W2017029622 @default.
• W2095064118 cites W2019292847 @default.
• W2095064118 cites W2022045852 @default.
• W2095064118 cites W2024595947 @default.
• W2095064118 cites W2024608895 @default.
• W2095064118 cites W2024882352 @default.
• W2095064118 cites W2025505190 @default.
• W2095064118 cites W2029375439 @default.
• W2095064118 cites W2031622530 @default.
• W2095064118 cites W2038446554 @default.
• W2095064118 cites W2040573057 @default.
• W2095064118 cites W2048598450 @default.
• W2095064118 cites W2051995363 @default.
• W2095064118 cites W2053194675 @default.
• W2095064118 cites W2053978050 @default.
• W2095064118 cites W2058023895 @default.
• W2095064118 cites W2059931977 @default.
• W2095064118 cites W2069438326 @default.
• W2095064118 cites W2080406638 @default.
• W2095064118 cites W2091650364 @default.
• W2095064118 cites W2091826365 @default.
• W2095064118 cites W2093264061 @default.
• W2095064118 cites W2098292750 @default.
• W2095064118 cites W2102148410 @default.
• W2095064118 cites W2107614745 @default.
• W2095064118 cites W2107653037 @default.
• W2095064118 cites W2113621045 @default.
• W2095064118 cites W2115470717 @default.
• W2095064118 cites W2120321567 @default.
• W2095064118 cites W2130566253 @default.
• W2095064118 cites W2130574175 @default.
• W2095064118 cites W2136277835 @default.
• W2095064118 cites W2137577190 @default.
• W2095064118 cites W2159606669 @default.
• W2095064118 cites W2160317132 @default.
• W2095064118 cites W2299621452 @default.
• W2095064118 cites W2314913625 @default.
• W2095064118 cites W2321888117 @default.
• W2095064118 cites W2327318658 @default.
• W2095064118 cites W2335752216 @default.
• W2095064118 doi "https://doi.org/10.1016/j.nucmedbio.2013.08.001" @default.
• W2095064118 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24090672" @default.
• W2095064118 hasPublicationYear "2013" @default.
• W2095064118 type Work @default.
• W2095064118 sameAs 2095064118 @default.
• W2095064118 citedByCount "30" @default.
• W2095064118 countsByYear W20950641182013 @default.
• W2095064118 countsByYear W20950641182014 @default.
• W2095064118 countsByYear W20950641182015 @default.
• W2095064118 countsByYear W20950641182016 @default.
• W2095064118 countsByYear W20950641182017 @default.
• W2095064118 countsByYear W20950641182018 @default.
• W2095064118 countsByYear W20950641182019 @default.
• W2095064118 countsByYear W20950641182020 @default.
• W2095064118 countsByYear W20950641182021 @default.
• W2095064118 countsByYear W20950641182022 @default.
• W2095064118 crossrefType "journal-article" @default.
• W2095064118 hasAuthorship W2095064118A5004769994 @default.
• W2095064118 hasAuthorship W2095064118A5022775390 @default.
• W2095064118 hasAuthorship W2095064118A5034838802 @default.
• W2095064118 hasAuthorship W2095064118A5049887641 @default.
• W2095064118 hasAuthorship W2095064118A5063090346 @default.
• W2095064118 hasAuthorship W2095064118A5070008388 @default.
• W2095064118 hasAuthorship W2095064118A5072886386 @default.
• W2095064118 hasConcept C134121241 @default.
• W2095064118 hasConcept C150903083 @default.
• W2095064118 hasConcept C151730666 @default.
• W2095064118 hasConcept C177322064 @default.
• W2095064118 hasConcept C181199279 @default.

• next